DANBURY, Conn., April 18 /PRNewswire-FirstCall/ -- Penwest Pharmaceuticals Co. will conduct a conference call on Thursday, April 27th at 11:00 a.m. ET to review its financial results for the first quarter of 2006, which will be released earlier that day. Operational developments and financial outlook will also be discussed on the call.
The conference call will include remarks by Jennifer Good, President and Chief Operating Officer, and Alan Joslyn, Ph.D., Senior Vice President of Research and Development.
Domestic Telephone Number: 800-895-3606 International Telephone Number: 785-424-1065 The conference ID is "Penwest." Please dial in 10 minutes prior to the scheduled start time.
The conference call will also be accessible live and as a replay on the Investor Relations section of the Penwest Web site at http://www.penwest.com.
If you have any questions, please contact Diane D'Alessandro of Penwest at 203-796-3700 or Caroline Gentile of Kekst and Company at 212-521-4800.
PenwestCONTACT: Diane D'Alessandro of Penwest, +1-203-796-3700; or CarolineGentile of Kekst and Company, +1-212-521-4800, for Penwest
Web site: http://www.penwest.com/
